Responses
Research Article
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab
Compose a Response to This Article
Other responses
No responses have been published for this article.